Comparative study for the efficacy, safety and quality of life in patients of chronic myeloid leukemia treated with Imatinib or Hydroxyurea

• Главные авторы: Parveen Jain (Автор), V. N. R. Das (Автор), Alok Ranjan (Автор), Rahul Chaudhary (Автор), Krishna Pandey (Автор)
• Формат: ‌
• Опубликовано: Wolters Kluwer Medknow Publications, 2013-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Objective: Chronic myeloid leukemia (CML) is a clonal hematopoietic disorder caused by acquired genetic defect in pluripotent stem cells characterized by acquisition of the philadelphia chromosome. The aim of this study was to compare the efficacy, safety and quality of life (QoL) in CML patients tr...